The sexist behaviour of immune checkpoint inhibitors in cancer therapy?

Author:

Botticelli Andrea12,Onesti Concetta Elisa12,Zizzari Ilaria3,Cerbelli Bruna4,Sciattella Paolo5,Occhipinti Mario1,Roberto Michela12,Di Pietro Francesca12,Bonifacino Adriana6,Ghidini Michele7,Vici Patrizia8,Pizzuti Laura8,Napoletano Chiara3,Strigari Lidia9,D’Amati Giulia4,Mazzuca Federica12,Nuti Marianna3,Marchetti Paolo12

Affiliation:

1. Medical Oncology Department, Sant’Andrea Hospital, Rome, Italy

2. Department of Clinical and Molecular Medicine, “Sapienza” University of Rome, Rome, Italy

3. Department of Experimental Medicine, “Sapienza” University of Rome, Rome, Italy

4. Department of Radiological Oncological and Pathological Sciences, “Sapienza” University of Rome, Rome, Italy

5. Statistical Department, “Sapienza” University of Rome, Rome, Italy

6. Breast Diagnosis and Treatment Unit, Sant’Andrea Hospital, “Sapienza” University of Rome, Rome, Italy

7. Oncology Unit, ASST Cremona, Cremona, Italy

8. Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy

9. Laboratory of Medical Physics and Expert Systems, IRCCS Regina Elena National Cancer Institute, Rome, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3